Policymaking for Orphan Drugs and Its Challenges
21PDF
TL;DRAbstract
The Orphan Drug Act of 1983 provides incentives to encourage the development of drugs for rare diseases, but available orphan drugs tend to be expensive and targeted to the more common of the rare diseases.
Chat with Paper
AI Agents for this Paper
The Orphan Drug Act of 1983 provides incentives to encourage the development of drugs for rare diseases, but available orphan drugs tend to be expensive and targeted to the more common of the rare diseases.
Keywords
Orphan drugMedicineBusinessBioinformaticsBiology
Chat
Click to start Chat